Prostrate Cancer Screening for Older Men

Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center (COPPER) finds Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings – one-third of which was for men in the over 75 age group.